Ginkgo Bioworks Holdings, Inc. (DNA): Depreciation & Amortization
$58.99M
Year ended 2025-12-31
+11.5%
3-year compound annual growth
+33.6%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $58.99M | -6.4% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $63.02M | -10.6% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $70.51M | +65.7% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $42.55M | +46.3% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $29.08M | +109.7% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $13.86M | +28.9% | 2023-03-13, From 2020-01-01 |
| 2019-12-31 | $10.76M | n/a | 2022-03-29, From 2019-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Ginkgo Bioworks Holdings, Inc. (DNA) | 2025-12-31 | $58.99M | -6.4% |
| REGENXBIO Inc. (RGNX) | 2025-12-31 | $15.62M | -3.7% |
| Beam Therapeutics Inc. (BEAM) | 2025-12-31 | $22.29M | +1.7% |
| Vaxart, Inc. (VXRT) | 2025-12-31 | $8.58M | -3.1% |
| Atara Biotherapeutics, Inc. (ATRA) | 2025-12-31 | $2.12M | -58.1% |
| Agenus Inc (AGEN) | 2025-12-31 | $10.00M | -25.1% |
| ImmunityBio, Inc. (IBRX) | 2025-12-31 | $15.53M | -11.6% |
| Iovance Biotherapeutics, Inc. (IOVA) | 2025-12-31 | $35.94M | -4.4% |
| Vericel Corp (VCEL) | 2025-12-31 | $11.54M | +109.7% |
Compare DNA, RGNX, BEAM, VXRT side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗